vs
Arch Capital Group（ACGL）与科迪华（CTVA）财务数据对比。点击上方公司名可切换其他公司
Arch Capital Group的季度营收约是科迪华的1.2倍（$4.5B vs $3.9B），Arch Capital Group净利率更高（23.2% vs -14.1%，领先37.3%），科迪华同比增速更快（-1.7% vs -3.3%），过去两年Arch Capital Group的营收复合增速更高（3.4% vs -6.7%）
百慕大注册上市企业Arch Capital Group面向全球提供保险、再保险及按揭保险服务，专注于特种类保险业务，承保保险业内难度较高的特殊风险。公司总部位于百慕大，在北美、欧洲、亚洲及澳洲共设有60个办事处，实现全球布局运营。
科迪华是一家美国农业科技企业，主营种子与作物保护产品，涵盖除草剂、杀虫剂、杀菌剂及生物制剂，业务覆盖全球110个国家，总部位于印第安纳州印第安纳波利斯，旗下大部分种子产品以先锋良种国际品牌销售。
ACGL vs CTVA — 直观对比
营收规模更大
ACGL
是对方的1.2倍
$3.9B
营收增速更快
CTVA
高出1.5%
-3.3%
净利率更高
ACGL
高出37.3%
-14.1%
两年增速更快
ACGL
近两年复合增速
-6.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $4.5B | $3.9B |
| 净利润 | $1.0B | $-552.0M |
| 毛利率 | — | 42.4% |
| 营业利润率 | — | -13.6% |
| 净利率 | 23.2% | -14.1% |
| 营收同比 | -3.3% | -1.7% |
| 净利润同比 | 82.4% | -1246.3% |
| 每股收益（稀释后） | $2.88 | $-0.80 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACGLCTVA
| Q1 26 | $4.5B | — | ||
| Q4 25 | $4.9B | $3.9B | ||
| Q3 25 | $5.1B | $2.6B | ||
| Q2 25 | $5.2B | $6.5B | ||
| Q1 25 | $4.7B | $4.4B | ||
| Q4 24 | $4.5B | $4.0B | ||
| Q3 24 | $4.7B | $2.3B | ||
| Q2 24 | $4.2B | $6.1B |
净利润ACGLCTVA
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.2B | $-552.0M | ||
| Q3 25 | $1.4B | $-320.0M | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $574.0M | $652.0M | ||
| Q4 24 | $935.0M | $-41.0M | ||
| Q3 24 | $988.0M | $-524.0M | ||
| Q2 24 | $1.3B | $1.1B |
毛利率ACGLCTVA
| Q1 26 | — | — | ||
| Q4 25 | — | 42.4% | ||
| Q3 25 | — | 37.2% | ||
| Q2 25 | — | 54.6% | ||
| Q1 25 | — | 47.0% | ||
| Q4 24 | — | 37.3% | ||
| Q3 24 | — | 32.7% | ||
| Q2 24 | — | 52.3% |
营业利润率ACGLCTVA
| Q1 26 | — | — | ||
| Q4 25 | — | -13.6% | ||
| Q3 25 | — | -14.1% | ||
| Q2 25 | — | 27.9% | ||
| Q1 25 | — | 17.7% | ||
| Q4 24 | — | 2.2% | ||
| Q3 24 | — | -27.2% | ||
| Q2 24 | — | 21.9% |
净利率ACGLCTVA
| Q1 26 | 23.2% | — | ||
| Q4 25 | 25.1% | -14.1% | ||
| Q3 25 | 26.4% | -12.2% | ||
| Q2 25 | 23.7% | 20.4% | ||
| Q1 25 | 12.3% | 14.8% | ||
| Q4 24 | 20.6% | -1.0% | ||
| Q3 24 | 20.9% | -22.5% | ||
| Q2 24 | 30.0% | 17.2% |
每股收益（稀释后）ACGLCTVA
| Q1 26 | $2.88 | — | ||
| Q4 25 | $3.33 | $-0.80 | ||
| Q3 25 | $3.56 | $-0.47 | ||
| Q2 25 | $3.23 | $1.92 | ||
| Q1 25 | $1.48 | $0.95 | ||
| Q4 24 | $2.41 | $-0.05 | ||
| Q3 24 | $2.56 | $-0.76 | ||
| Q2 24 | $3.30 | $1.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $24.0M | $4.5B |
| 总债务越低越好 | — | $1.7B |
| 股东权益账面价值 | $24.2B | $24.1B |
| 总资产 | $81.4B | $42.8B |
| 负债/权益比越低杠杆越低 | — | 0.07× |
8季度趋势，按日历期对齐
现金及短期投资ACGLCTVA
| Q1 26 | $24.0M | — | ||
| Q4 25 | $993.0M | $4.5B | ||
| Q3 25 | $1.1B | $2.6B | ||
| Q2 25 | $983.0M | $2.1B | ||
| Q1 25 | $1.2B | $2.0B | ||
| Q4 24 | $979.0M | $3.2B | ||
| Q3 24 | $1.0B | $2.5B | ||
| Q2 24 | $1.0B | $2.0B |
总债务ACGLCTVA
| Q1 26 | — | — | ||
| Q4 25 | — | $1.7B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $1.7B | ||
| Q1 25 | — | $1.8B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | — | $2.5B |
股东权益ACGLCTVA
| Q1 26 | $24.2B | — | ||
| Q4 25 | $24.2B | $24.1B | ||
| Q3 25 | $23.7B | $25.2B | ||
| Q2 25 | $23.0B | $25.9B | ||
| Q1 25 | $21.5B | $24.3B | ||
| Q4 24 | $20.8B | $23.8B | ||
| Q3 24 | $22.3B | $24.7B | ||
| Q2 24 | $20.7B | $25.2B |
总资产ACGLCTVA
| Q1 26 | $81.4B | — | ||
| Q4 25 | $79.2B | $42.8B | ||
| Q3 25 | $79.2B | $42.2B | ||
| Q2 25 | $78.8B | $41.8B | ||
| Q1 25 | $75.2B | $42.1B | ||
| Q4 24 | $70.9B | $40.8B | ||
| Q3 24 | $73.7B | $41.9B | ||
| Q2 24 | $65.5B | $41.5B |
负债/权益比ACGLCTVA
| Q1 26 | — | — | ||
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.07× | ||
| Q1 25 | — | 0.07× | ||
| Q4 24 | — | 0.08× | ||
| Q3 24 | — | 0.08× | ||
| Q2 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.2B | $4.4B |
| 自由现金流经营现金流 - 资本支出 | — | $4.2B |
| 自由现金流率自由现金流/营收 | — | 106.2% |
| 资本支出强度资本支出/营收 | — | 5.7% |
| 现金转化率经营现金流/净利润 | 1.13× | — |
| 过去12个月自由现金流最近4个季度 | — | $2.8B |
8季度趋势，按日历期对齐
经营现金流ACGLCTVA
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.4B | $4.4B | ||
| Q3 25 | $2.2B | $193.0M | ||
| Q2 25 | $1.1B | $947.0M | ||
| Q1 25 | $1.5B | $-2.1B | ||
| Q4 24 | $1.6B | $4.2B | ||
| Q3 24 | $2.0B | $130.0M | ||
| Q2 24 | $1.5B | $451.0M |
自由现金流ACGLCTVA
| Q1 26 | — | — | ||
| Q4 25 | $1.4B | $4.2B | ||
| Q3 25 | $2.2B | $36.0M | ||
| Q2 25 | $1.1B | $829.0M | ||
| Q1 25 | $1.4B | $-2.2B | ||
| Q4 24 | $1.6B | $4.0B | ||
| Q3 24 | $2.0B | $-24.0M | ||
| Q2 24 | $1.5B | $337.0M |
自由现金流率ACGLCTVA
| Q1 26 | — | — | ||
| Q4 25 | 28.2% | 106.2% | ||
| Q3 25 | 42.6% | 1.4% | ||
| Q2 25 | 21.3% | 12.8% | ||
| Q1 25 | 31.0% | -49.9% | ||
| Q4 24 | 34.3% | 100.4% | ||
| Q3 24 | 42.5% | -1.0% | ||
| Q2 24 | 35.6% | 5.5% |
资本支出强度ACGLCTVA
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | 5.7% | ||
| Q3 25 | 0.2% | 6.0% | ||
| Q2 25 | 0.2% | 1.8% | ||
| Q1 25 | 0.2% | 2.1% | ||
| Q4 24 | 0.3% | 4.6% | ||
| Q3 24 | 0.3% | 6.6% | ||
| Q2 24 | 0.3% | 1.9% |
现金转化率ACGLCTVA
| Q1 26 | 1.13× | — | ||
| Q4 25 | 1.13× | — | ||
| Q3 25 | 1.62× | — | ||
| Q2 25 | 0.91× | 0.72× | ||
| Q1 25 | 2.54× | -3.23× | ||
| Q4 24 | 1.68× | — | ||
| Q3 24 | 2.04× | — | ||
| Q2 24 | 1.20× | 0.43× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACGL
暂无分部数据
CTVA
| Corn | $1.4B | 35% |
| Herbicides | $1.1B | 27% |
| Insecticides | $488.0M | 12% |
| Fungicides | $272.0M | 7% |
| Biologicals | $191.0M | 5% |
| Soybean | $164.0M | 4% |
| Other | $160.0M | 4% |
| Otheroilseeds | $94.0M | 2% |
